Research analysts at Citigroup assumed coverage on shares of athenahealth (NASDAQ:ATHN) in a report released on Thursday, The Fly reports. The brokerage set a “neutral” rating on the health services provider’s stock.

Other equities analysts have also issued reports about the stock. Oppenheimer reiterated a “buy” rating and set a $184.00 target price on shares of athenahealth in a report on Friday, October 20th. Piper Jaffray Companies reiterated a “buy” rating and set a $167.00 target price on shares of athenahealth in a report on Tuesday, October 17th. SunTrust Banks reissued a “buy” rating and set a $156.00 price target on shares of athenahealth in a research report on Wednesday, October 25th. Leerink Swann set a $155.00 price target on shares of athenahealth and gave the company a “hold” rating in a research report on Thursday, October 19th. Finally, Jefferies Group reduced their price target on shares of athenahealth from $135.00 to $120.00 and set a “hold” rating for the company in a research report on Friday, September 15th. One analyst has rated the stock with a sell rating, seventeen have given a hold rating and ten have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $143.29.

Shares of athenahealth (ATHN) opened at $135.37 on Thursday. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35. athenahealth has a 1-year low of $95.01 and a 1-year high of $158.66. The company has a market cap of $5,438.40, a PE ratio of 175.81, a price-to-earnings-growth ratio of 3.18 and a beta of 1.58.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.06. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business had revenue of $304.60 million during the quarter, compared to analyst estimates of $310.52 million. During the same period last year, the business posted $0.60 earnings per share. athenahealth’s quarterly revenue was up 10.1% compared to the same quarter last year. equities analysts anticipate that athenahealth will post 1.22 EPS for the current fiscal year.

In other athenahealth news, Director Amy Abernethy sold 500 shares of the business’s stock in a transaction on Tuesday, December 26th. The shares were sold at an average price of $134.18, for a total value of $67,090.00. Following the sale, the director now owns 4,045 shares in the company, valued at approximately $542,758.10. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Bradford Kyle Armbrester sold 1,000 shares of the business’s stock in a transaction on Friday, October 27th. The stock was sold at an average price of $128.56, for a total transaction of $128,560.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 64,700 shares of company stock worth $8,705,472. Corporate insiders own 3.20% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Turner Investments LLC purchased a new stake in shares of athenahealth during the 2nd quarter valued at about $105,000. Parkside Financial Bank & Trust raised its position in shares of athenahealth by 13.0% during the 3rd quarter. Parkside Financial Bank & Trust now owns 811 shares of the health services provider’s stock valued at $102,000 after buying an additional 93 shares in the last quarter. Advisors Asset Management Inc. raised its position in shares of athenahealth by 1.9% during the 3rd quarter. Advisors Asset Management Inc. now owns 895 shares of the health services provider’s stock valued at $113,000 after buying an additional 17 shares in the last quarter. First Quadrant L P CA purchased a new stake in shares of athenahealth during the 3rd quarter valued at about $114,000. Finally, Bessemer Group Inc. raised its position in shares of athenahealth by 13.7% during the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after buying an additional 113 shares in the last quarter.

COPYRIGHT VIOLATION WARNING: “athenahealth (ATHN) Coverage Initiated by Analysts at Citigroup” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.americanbankingnews.com/2018/01/04/athenahealth-athn-coverage-initiated-by-analysts-at-citigroup.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

The Fly

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.